Ponatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)

University Tor Vergata, Roma

UCL Bruxelles, Brussels

Royal North Shore Hospital, St Leonards

UZ Leuven, Leuven

Peter MacCallum Cancer Centre, East Melbourne

Alfred Hospital, Box Hill

Princess Alexandra Hospital, Woolloongabba

Royal Adelaide Hospital, Adelaide

Hopital Archet, Nice

Hospital Clinic, Barcelona

University of Turin, Orbassano (TO)

Charite - Universitatsmedizin Berlin,, Berlin

Karolinska Hospital, Stockholm

University of Milano Bicocca, Monza

Lund University, Lund

La Paz, Madrid

Hopital de Purpan, Toulouse

Institut Bergonie, Bordeaux

Hospital Universitario de Salamanca, Salamanca

Universita di Bologna, Bologna

University of Modena, Modena

Hospital Clinico of Valencia, Valencia

Chu Brabois, Nancy

Hopital Claude Huriez CHRU, Lille

Klinikum der Goethe Universitat,, Frankfurt

University of Heidelberg, Mannheim

Hopital Edouard Herriot, Pierre-Bénite

Hopital St. Louis, Paris

University Hospital Uppsala, Uppsala

Hopital Andre Mignot, Le Chesnay

III. Med. Klinik und Poliklinik, München

Entre Hospitalier Universitaire, Poitiers

Singapore General Hospital, Singapore

Universitatsklinikum Jena, Jena

VU University Medical Center, Amsterdam

University Medical Center Groeningen, Groningen

The Catholic University of Korea, Seoul St.Mary's Hospital, Seoul

Gartnavel General Hospital, Glasgow

Royal Liverpool University Hospital, Liverpool

Hammersmith Hospital, London

Royal Victoria Infirmary, Newcastle

University of Nottingham, Nottingham